Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.230
+0.120 (10.81%)
At close: Mar 6, 2026, 4:00 PM EST
1.220
-0.010 (-0.81%)
After-hours: Mar 6, 2026, 6:24 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $160.47 million as of March 6, 2026. Its market cap has increased by 69.66% in one year.
Market Cap
160.47M
Enterprise Value
137.74M
1-Year Change
69.66%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $160.47M, a decrease of -34.13%. That is a compound annual growth rate of -5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 144.82M | 125.58% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 159.83M |
| Innate Pharma | 152.59M |
| Corbus Pharmaceuticals Holdings | 148.60M |
| Unicycive Therapeutics | 146.79M |
| Adagene | 142.34M |
| Zentalis Pharmaceuticals | 141.48M |
| Artiva Biotherapeutics | 140.89M |
| Sangamo Therapeutics | 140.09M |